(Health-NewsWire.Net, June 16, 2016 ) Scope of the report
The report titled The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019) provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs involved in the treatment of chronic pain. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall chronic pain therapy market has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Zogenix Inc., Egalet Corporation and NektarTheropeutics are profiled.
Segment Coverage
Oxycodone Hydrocodone Morphine Hydromorphone Fentanyl Dihydrocodeine Methadone
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=240177
Company Coverage
Zogenix Inc. Egalet Corporation NektarTheropeutics
Executive Summary
Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating.
The US chronic pain therapy market is expected to experience slow pace of growth in the near future. The major opioids used for medication in chronic pain are Oxycodone, Hydrocodone, Fentanyl, Methadone, Morphine, Hydromorphone and Dihydrocodeine. Compared to other opioids, hydrocodone products, the most commonly prescribed opioid and the most commonly prescribed pharmaceutical products in the United States, are growing at a substantial pace in the overall chronic pain therapy market. In the oxycodone business domain, the expected launch of Egalet 002 in the second quarter of 2015 by the leading player Egalet will change the dynamics of this domain as currently Oxycotin dominates the oxycodone market.
Read All Therapeutic Area Market Research Reports @ http://www.researchmoz.us/therapeutic-area-market-reports-37.html
Table of Content
1. Executive summary 2. Introduction: Chronic Pain 3. The US Chronic Pain Therapy Market 3.1 Opioid Sales in US Chronic Pain Market: Sizing & Growth 3.2 Opioid Sales in US Chronic Pain Market - Forecast: Sizing & Growth 4. The US Chronic Pain Therapy Market: Segment Analysis 4.1 The US Oxycodone Market: Size and Growth 4.2 The US Methadone Market: Size and Growth 4.3 The US Morphine Market: Size and Growth 4.4 The US Hydromorphone Market: Size and Growth 4.5 The US Hydrocodone Market: Size and Growth 4.6 The US Dihydrocodeine Market: Size and Growth 4.7 The US Fentanyl Market: Size and Growth 5. The US Chronic Pain Therapy: Market Share Analysis 6. Growth Drivers and Challenges:The US Chronic Pain Therapy Market 6.1 Growth Drivers 6.1.1 Rising Healthcare Expenditures 6.1.2 Rise in Aging Demographics 6.1.3 Economic Development 6.2 Market Challenges
Contact Us:
Mr. Nachiket Albany NY - 12207 United States Tel: +1-518-621-2074 Tel: 866-997-4948 (Us-Canada Toll Free) Email: sales@researchmoz.us Follow us on LinkedIn at: http://bit.ly/1TBmnVG
About ResearchMoz
ResearchMoz is the worlds fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMozs service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
|